NDMA Contamination Discovered in Diabetes Drug In December 2019, the U.S. Food and Drug Administration (FDA) began an investigation into Metformin, a drug commonly used to treat type-2 diabetes. After

Holding Nursing Homes Accountable for Negligence It should come as no surprise that nursing homes are uniquely vulnerable to COVID-19, as the elderly face the highest risks of serious illness

Despite Thousands of COVID-19 Deaths, the Federal Government Continues to Discuss Eliminating Vital Employees As of May 1st, USA Today released an estimate that nursing home patients and staff accounted

As guidance from the White House lags behind official recommendations, cities and states are making their own moves to slow the spread of the novel coronavirus. Many large businesses have

On March 3rd, the U.S. Department of Justice (DOJ) launched its National Nursing Home Initiative to increase awareness of—and legal action against—nursing home abuse. The program, a partnership between the

A New Federal Safety Commission Is Among the Post-Pandemic Changes to Protect Nursing Homes from Future Outbreaks Yesterday, President Trump announced a new task force to analyze nursing home response

The FDA Just Told Manufacturers to Remove Ranitidine Drugs from Shelves On April 1, 2020, the U.S. Food and Drug Administration (FDA) announced a total recall of all prescription and

When do the dangers of a drug outweigh its benefits? Pharmaceutical company Eisai, Inc. and the FDA disagree—but thankfully, the FDA’s viewpoint has prevailed. Belviq, active ingredient lorcaserin, has been

“Don’t worry, its only the elderly that are dying”. In the last month, I have heard this statement over a dozen times. Today I heard the much more bothersome “boomer

As of Friday, March 6th, coronavirus (COVID-19) infections were confirmed in 247 Americans across 21 states. Fourteen of those patients have died, 9 of whom lived in the same Washington